Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2012

01-06-2012 | Original Article

Mean platelet volume predicting carotid atherosclerosis in atherothrombotic ischemic stroke

Authors: J. C. Arévalo-Lorido, J. Carretero-Gómez, P. Villar-Vaca

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2012

Login to get access

Abstract

Background

Platelets are involved in atherosclerosis. Mean platelet volume (MPV) could be a marker of platelet activation. We aim to determine whether MPV levels were correlated with the presence of atherosclerotic disease in carotid arteries of patients with stroke.

Methods

We recruited 215 patients with atherothrombotic stroke. All the participants underwent ultrasonographic evaluation of their extracranial carotid arteries. MPV was measured in automated hematology analysis system. The subjects were divided according to plaques and severity of carotid stenosis. Univariate and multivariate statistical analyses and a ROC curve to predict carotid stenosis were performed.

Results

Univariate analysis showed a positive relationship between MPV and the degree of carotid atherosclerosis (p < 0.00007), and with carotid intima to media thickness (p < 0.00002). In ROC curve, a MPV cut-off of 11.25 fl was obtained for a sensibility of 70% and a specificity of 71% (p < 0.02). Multivariate analysis showed significant correlation with severity of carotid stenosis, when MPV was higher than 11.25 fl (OR: 2.9, p < 0.00007).

Conclusions

Our results indicate that an elevated MPV could be an easily measurable marker of severity of carotid stenosis in patients with atherothrombotic stroke.
Literature
1.
go back to reference Smith NM, Pathansali R, Bath PM (1999) Platelets and stroke. Vasc Med 4:165–172PubMed Smith NM, Pathansali R, Bath PM (1999) Platelets and stroke. Vasc Med 4:165–172PubMed
2.
go back to reference Borisoff JI, Sprouk HMH, Cate H (2011) The hemostatic system as a modulator of atherosclerosis. N Engl J Med 364:1746–1760CrossRef Borisoff JI, Sprouk HMH, Cate H (2011) The hemostatic system as a modulator of atherosclerosis. N Engl J Med 364:1746–1760CrossRef
3.
go back to reference Khandelar MM, Khurana AS, Deshmukh SD, Lakrani AL, Katdare AD, Inamdar AK (2006) Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol 59:146–149CrossRef Khandelar MM, Khurana AS, Deshmukh SD, Lakrani AL, Katdare AD, Inamdar AK (2006) Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol 59:146–149CrossRef
4.
go back to reference Fisher M, Levine PH, Fullerton AL et al (1982) Marker proteins of platelet activation in cerebrovascular disease. Arch Neurol 39:692–695PubMedCrossRef Fisher M, Levine PH, Fullerton AL et al (1982) Marker proteins of platelet activation in cerebrovascular disease. Arch Neurol 39:692–695PubMedCrossRef
5.
go back to reference Butterworth R, Bath P (1998) The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets 9:359–364PubMedCrossRef Butterworth R, Bath P (1998) The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets 9:359–364PubMedCrossRef
6.
go back to reference Endler G, Klimesch A, Sunder-Plassmann H et al (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399–404PubMedCrossRef Endler G, Klimesch A, Sunder-Plassmann H et al (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399–404PubMedCrossRef
7.
go back to reference Sharpe P, Trinick T (1993) Mean platelet volume in diabetes mellitus. Q J Med 86:739–742PubMed Sharpe P, Trinick T (1993) Mean platelet volume in diabetes mellitus. Q J Med 86:739–742PubMed
8.
go back to reference Greissenegger S, Endler C, Hsieh K, Teutschert S, Mannhalter C, Lalouschek W (2004) Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 35:1688–1691CrossRef Greissenegger S, Endler C, Hsieh K, Teutschert S, Mannhalter C, Lalouschek W (2004) Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 35:1688–1691CrossRef
9.
go back to reference Martin JF, Bath PMW, Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338:1409–1411PubMedCrossRef Martin JF, Bath PMW, Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338:1409–1411PubMedCrossRef
10.
go back to reference Bath P, Algert CH, Chapman N, Neal B, for the PROGRESS Collaborative Group (2004) Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 35:622–626PubMedCrossRef Bath P, Algert CH, Chapman N, Neal B, for the PROGRESS Collaborative Group (2004) Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 35:622–626PubMedCrossRef
11.
go back to reference Adams HP Jr, Bendixen BH, Kappelle LJ, TOAST Investigators (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41PubMedCrossRef Adams HP Jr, Bendixen BH, Kappelle LJ, TOAST Investigators (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41PubMedCrossRef
12.
go back to reference Hacke W, Kaste M, Fieschi C, for the second European-Australasian Acute Stroke Study Investigator et al (1998) Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352:1245–1251PubMedCrossRef Hacke W, Kaste M, Fieschi C, for the second European-Australasian Acute Stroke Study Investigator et al (1998) Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352:1245–1251PubMedCrossRef
13.
go back to reference Pocock SJ, Mc Cormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP, on behalf of the INDANA project steering committee (2001) A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 323:75–81PubMedCrossRef Pocock SJ, Mc Cormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP, on behalf of the INDANA project steering committee (2001) A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 323:75–81PubMedCrossRef
14.
go back to reference Rosfors S, Hallerstam S, Jensen-Urstad K, Zetterling M, Carlström C (1998) Relantionship between intima-media thickness in the common carotid artery and atherosclerosis in the carotid bifurcation. Stroke 29:1378–1382PubMedCrossRef Rosfors S, Hallerstam S, Jensen-Urstad K, Zetterling M, Carlström C (1998) Relantionship between intima-media thickness in the common carotid artery and atherosclerosis in the carotid bifurcation. Stroke 29:1378–1382PubMedCrossRef
15.
go back to reference Kiechl S, Willeit J, for the Bruneck study group (1999) The natural course of atherosclerosis I: Incidence and progression. Arterioscler Thromb Vasc Biol 19:1484–1490CrossRef Kiechl S, Willeit J, for the Bruneck study group (1999) The natural course of atherosclerosis I: Incidence and progression. Arterioscler Thromb Vasc Biol 19:1484–1490CrossRef
16.
go back to reference Kiechl S, Willeit J, for the Bruneck study group (1999) The natural course of atherosclerosis II: vascular remodelling. Arterioscler Thromb Vasc Biol 19:1491–1498PubMedCrossRef Kiechl S, Willeit J, for the Bruneck study group (1999) The natural course of atherosclerosis II: vascular remodelling. Arterioscler Thromb Vasc Biol 19:1491–1498PubMedCrossRef
17.
go back to reference Willeit J, Kiechl S, Oberhollenzer F et al (2000) Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol 20:529–537PubMedCrossRef Willeit J, Kiechl S, Oberhollenzer F et al (2000) Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol 20:529–537PubMedCrossRef
18.
go back to reference Burger PC, Wagner DD (2003) Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101:2661–2666PubMedCrossRef Burger PC, Wagner DD (2003) Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101:2661–2666PubMedCrossRef
19.
go back to reference Catellier DJ, Aleksic N, Folsom AR, Boerwinkle E (2008) Atherosclerosis risk in communities (ARIC) carotid MRI flow cytometry study of monocyte and platelets markers: intraindividual variability and reliability. Clin Chem 54:1363–1371PubMedCrossRef Catellier DJ, Aleksic N, Folsom AR, Boerwinkle E (2008) Atherosclerosis risk in communities (ARIC) carotid MRI flow cytometry study of monocyte and platelets markers: intraindividual variability and reliability. Clin Chem 54:1363–1371PubMedCrossRef
20.
go back to reference Yilmaz MB, Cihan G, Guray Y et al (2008) Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis 26:49–54PubMedCrossRef Yilmaz MB, Cihan G, Guray Y et al (2008) Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis 26:49–54PubMedCrossRef
21.
go back to reference Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GYH (2004) Platelets indexes in relation to target organ damage in high-risk hypertensive patients. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). JACC 44:415–422PubMed Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GYH (2004) Platelets indexes in relation to target organ damage in high-risk hypertensive patients. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). JACC 44:415–422PubMed
22.
go back to reference Arévalo Lorido JC, Carretero Gómez J (2009) C-reactive protein and carotid intima-media thickness in atherothrombotic ischemic stroke. Med Clin (Barc) 133:496–500CrossRef Arévalo Lorido JC, Carretero Gómez J (2009) C-reactive protein and carotid intima-media thickness in atherothrombotic ischemic stroke. Med Clin (Barc) 133:496–500CrossRef
23.
go back to reference Jagroop IA, Tsiara S, Mikhailidis DP (2003) Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 14:335–336PubMedCrossRef Jagroop IA, Tsiara S, Mikhailidis DP (2003) Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 14:335–336PubMedCrossRef
24.
go back to reference Jagroop IA, Mikhailidis DP (2003) Mean platelet volume as an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 120:169–170PubMedCrossRef Jagroop IA, Mikhailidis DP (2003) Mean platelet volume as an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 120:169–170PubMedCrossRef
Metadata
Title
Mean platelet volume predicting carotid atherosclerosis in atherothrombotic ischemic stroke
Authors
J. C. Arévalo-Lorido
J. Carretero-Gómez
P. Villar-Vaca
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2012
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-011-0755-8

Other articles of this Issue 2/2012

Irish Journal of Medical Science (1971 -) 2/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.